Try our Advanced Search for more refined results
February 26, 2016
IMMUNEX CORPORATION et al v. SANDOZ INC. et al
Case Number:
2:16-cv-01118
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 09, 2019
Amgen Patents Beat Sandoz Validity Check In Biosimilar Fight
A New Jersey federal judge Friday rejected Sandoz Inc.'s attempt to invalidate two patents covering Amgen subsidiary Immunex Corp.'s blockbuster immunosuppressant Enbrel, stalling Sandoz's aim to launch a biosimilar version of the drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login